Concepedia

Author

Marian Benroubi

Polyclinic General Hospital

Also Known As

E Pangalos, Iakovos Avramidis, M Benroubi, M. Benroubi, Marian Benroubi

22

Publications

1.1K

Citations

13

H-Index

4

Concepts

All Affiliations

Polyclinic General HospitalWindsor Regional HospitalHôpital Jean-VerdierAssistance Publique – Hôpitaux de ParisJuntendo University
MB

About

Marian Benroubi is an author at Polyclinic General Hospital specializing in diabetes, pharmacotherapy, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

14

2

Diabetes

1

1

14

3

Pharmacology

1

1

14

4

Pharmacotherapy

1

1

14

Marian Benroubi

×

11

Publications

657

Citations

11

H-Index

YearCitations

Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)

Francesco Giorgino, Marian Benroubi, Jui‐Hung Sun,

Diabetes Care

2015

249

The IMPROVE™ study - a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts

P. Valensi, Marian Benroubi, Janusz Gumprecht,

International Journal of Clinical Practice

2008

87

Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix<sup>®</sup>30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study

P. Valensi, Marian Benroubi, Jakub Gumprecht,

International Journal of Clinical Practice

2009

80

Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix<sup>®</sup>30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE<sup>™</sup>observational study

Janusz Gumprecht, Marian Benroubi, Ryuzo Kawamori,

International Journal of Clinical Practice

2009

46

Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*

Stephen C. Jones, Marian Benroubi, Conxa Castell,

Current Medical Research and Opinion

2009

46

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix<sup>®</sup>30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study

Shreyas Shah, Marian Benroubi, Jakub Gumprecht,

International Journal of Clinical Practice

2009

44

Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries

Andreas Liebl, Stephen C. Jones, Marian Benroubi,

Current Medical Research and Opinion

2011

35

Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study

Aytekin Oğuz, Marian Benroubi, Kerstin Brismar,

Current Medical Research and Opinion

2013

28

Clinical Outcomes After Insulin Initiation in Patients with Type 2 Diabetes: 24-Month Results from INSTIGATE

Andreas Liebl, Steven M. Jones, Albert Goday,

Diabetes Therapy

2012

15

Efficacy and Safety of Once Weekly Dulaglutide vs. Insulin Glargine in Combination with Metformin and Glimepiride in Type 2 Diabetes Patients (AWARD-2)

Francesco Giorgino, Marian Benroubi, Jui‐Hung Sun,

Canadian Journal of Diabetes

2014

14

Page 1